SERUM SORUBLE CD27 LEVEL DETERMINES CLINICAL OUTCOME IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN RITUXIMAB ERA

被引：0
|
作者：
Coto, N.
Tsurumi, H. [1 ]
Kanemura, N. [1 ]
Kasahara, S. [1 ]
Hara, T. [1 ]
Kito, Y. [2 ]
Takami, T. [2 ]
Moriwaki, H. [1 ]
Nakamura, H. [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan
[2] Gifu Univ, Grad Sch Med, Dept Immunopathol, Gifu, Japan
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0671
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [31] Central Nervous System Events In Patients with Diffuse Large B-Cell Lymphoma In the Rituximab Era
    Tomita, Naoto
    Yokoyama, Masahiro
    Yamamoto, Wataru
    Watanabe, Reina
    Shimazu, Yutaka
    Tsunoda, Saburo
    Masaki, Yasufumi
    Hashimoto, Chizuko
    Murayama, Kayoko
    Yano, Takahiro
    Okamoto, Rumiko
    Kikuchi, Ako
    Tamura, Kazuo
    Sato, Kazuya
    Sunami, Kazutaka
    Shibayama, Hirohiko
    Takimoto, Rishu
    Oshima, Rika
    Hatta, Yoshihiro
    Moriuchi, Yoshiyuki
    Kinoshita, Tomohiro
    Yamamoto, Masahide
    Numata, Ayumi
    Ishigatsubo, Yoshiaki
    Takeuchi, Kengo
    BLOOD, 2010, 116 (21) : 1610 - 1610
  • [32] Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era
    Al-Juhaishi, Taha
    Al-Kindi, Sadeer G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 : 146 - 149
  • [33] Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era
    Tomita, Naoto
    Yokoyama, Masahiro
    Yamamoto, Wataru
    Watanabe, Reina
    Shimazu, Yutaka
    Masaki, Yasufumi
    Tsunoda, Saburo
    Hashimoto, Chizuko
    Murayama, Kayoko
    Yano, Takahiro
    Okamoto, Rumiko
    Kikuchi, Ako
    Tamura, Kazuo
    Sato, Kazuya
    Sunami, Kazutaka
    Shibayama, Hirohiko
    Takimoto, Rishu
    Ohshima, Rika
    Hatta, Yoshihiro
    Moriuchi, Yukiyoshi
    Kinoshita, Tomohiro
    Yamamoto, Masahide
    Numata, Ayumi
    Ishigatsubo, Yoshiaki
    Takeuchi, Kengo
    CANCER SCIENCE, 2012, 103 (02) : 245 - 251
  • [34] Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Yoon, Shinkyo
    Yoon, Dok Hyun
    Kim, Shin
    Lee, Kyoungmin
    Kang, Eun Hee
    Lee, Sang-wook
    Park, Chan-Jeoung
    Park, Chan-Sik
    Huh, Jooryung
    Suh, Cheolwon
    BLOOD, 2014, 124 (21)
  • [35] Is there any role for transplantation in the rituximab era for diffuse large B-cell lymphoma?
    Gisselbrecht, Christian
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2012, : 410 - 416
  • [36] High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
    Cardesa-Salzmann, Teresa M.
    Colomo, Luis
    Gutierrez, Gonzalo
    Chan, Wing C.
    Weisenburger, Dennis
    Climent, Fina
    Gonzalez-Barca, Eva
    Mercadal, Santiago
    Arenillas, Leonor
    Serrano, Sergio
    Tubbs, Ray
    Delabie, Jan
    Gascoyne, Randy D.
    Connors, Joseph M.
    Mate, Jose L.
    Rimsza, Lisa
    Braziel, Rita
    Rosenwald, Andreas
    Lenz, Georg
    Wright, George
    Jaffe, Elaine S.
    Staudt, Louis
    Jares, Pedro
    Lopez-Guillermo, Armando
    Campo, Elias
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (07): : 996 - 1001
  • [37] Clinical features and outcome of the patients with sinonasal tract diffuse large B-cell lymphoma in the pre-rituximab and rituximab eras
    Vahamurto, Pauli
    Mannisto, Susanna
    Pollari, Marjukka
    Karjalainen-Lindsberg, Marja-Liisa
    Makitie, Antti A.
    Leppa, Sirpa
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 102 (06) : 457 - 464
  • [38] Peripheral Blood Lymphocyte/Monocyte Ratio Predicts Outcome in Follicular Lymphoma and in Diffuse Large B-Cell Lymphoma Patients in the Rituximab Era
    Belotti, Angelo
    Doni, Elisa
    Bolis, Silvia
    Rossini, Fausto
    Casaroli, Ivana
    Pezzatti, Sara
    Pogliani, Enrico Maria
    Pioltelli, Pietro Enrico
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (04): : 208 - 213
  • [39] Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era
    Sato, Ai
    Nakamura, Naoya
    Kojima, Minoru
    Ohmachi, Ken
    Carreras, Joaquim
    Kikuti, Yara Yukie
    Numata, Hiroki
    Ohgiya, Daisuke
    Tazume, Kei
    Amaki, Jun
    Moriuchi, Makiko
    Miyamoto, Mitsuki
    Aoyama, Yasuyuki
    Kawai, Hidetsugu
    Ichiki, Akifumi
    Hara, Ryujiro
    Kawada, Hiroshi
    Ogawa, Yoshiaki
    Ando, Kiyoshi
    CANCER SCIENCE, 2014, 105 (09) : 1170 - 1175
  • [40] Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience
    Nishikawa, Hiroki
    Tsudo, Mitsuru
    Osaki, Yukio
    ONCOLOGY REPORTS, 2012, 28 (03) : 835 - 840
12345